HORIBA UK will be marking its 70th anniversary at IBMS Congress later this month, where delegates are invited to join the celebrations and also to see the company’s newly launched fully automated haemostasis analysers.
HORIBA is expanding its coagulation range with the UK launch of its new fully automated haemostasis analysers - the high-capacity Yumizen G1500h/G1550h and benchtop Yumizen G800h/G850h. Both can improve accuracy by readily identifying potentially problematic samples through detection and analysis of haemolysis, icterus and lipaemia (HIL) interferences per coagulation test, and automatically checking the primary tube for high and low fill levels. Pictured above is the G1550h.
Other product highlights will include new clinical chemistry reagents now available from HORIBA UK, such as the unique POINTE glucose-6-phosphate dehydrogenase (G6PD) assay used for the quantitative determination of G6PD enzyme activity in blood. This important cell function assay is CE-marked and can be automated on HORIBA’s Pentra C400 clinical chemistry analyser, as well as those of other manufacturers.
Also to be seen at IBMS Congress for the first time will be HORIBA’s recently introduced Cube S tube sorter. This robotic workstation can manage pre and post analytical sorting, storing and tracking of sample tubes within laboratories, enabling them to improve productivity and efficiency in their workflows.
Visitors to stand 715 will also have the opportunity to see HORIBA’s new products and explore its full range of haematology, haemostasis and clinical chemistry solutions. Additionally, they can discuss with the team any special requirements, from point-of-care testing through to hub-and-spoke laboratories, to establish the best options for current and future needs.
IBMS Congress takes place 25-28 September 2023, at The International Convention Centre (ICC), Birmingham.